Amphastar Pharmaceuticals (AMPH) FCF Margin Growth (3y) (2016 - 2026)
Amphastar Pharmaceuticals (AMPH) FCF Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 213.00 |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 2,102.00 |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 180.00 |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 1,592.00 |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -291.00 |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | -2,476.00 |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 1,604.00 |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 934.42 Mn | 644.30 Mn | 93.47 Mn | -824.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -824.00 |
| Mar 31, 2026 | 344.00 |
| Dec 31, 2025 | 351.00 |
| Sep 30, 2025 | -748.00 |
| Jun 30, 2025 | 2,316.00 |
| Mar 31, 2025 | -2,026.00 |
| Dec 31, 2024 | -3,146.00 |
| Sep 30, 2024 | 4,198.00 |
| Jun 30, 2024 | 817.00 |
| Mar 31, 2024 | 1,096.00 |
| Dec 31, 2023 | -455.00 |
| Sep 30, 2023 | 2,618.00 |
| Jun 30, 2023 | 910.00 |
| Mar 31, 2023 | 2,978.00 |
| Dec 31, 2022 | 4,665.00 |
| Sep 30, 2022 | 3,747.00 |
| Jun 30, 2022 | -7,778.00 |
| Mar 31, 2022 | 5,960.00 |
| Dec 31, 2021 | 2,087.00 |
| Sep 30, 2021 | -5,654.00 |